|
Volumn 16, Issue 4, 2003, Pages 243-252
|
Medical and Other Noncontraceptive Uses of Combined Oral Contraceptives
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONJUGATED ESTROGEN;
CONTRACEPTIVE AGENT;
ESTRADIOL;
ESTROGEN;
ORAL CONTRACEPTIVE AGENT;
PLACEBO;
ACNE;
BONE DENSITY;
BREAKTHROUGH BLEEDING;
CLINICAL PRACTICE;
CLINICAL PROTOCOL;
COLON CANCER;
CONFIDENTIALITY;
DIAGNOSTIC TEST;
DOSE RESPONSE;
DRUG APPROVAL;
DRUG CHOICE;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG PACKAGING;
DRUG TOLERABILITY;
DRUG UTILIZATION;
DYSMENORRHEA;
ECHOGRAPHY;
ENDOMETRIOSIS;
EVIDENCE BASED MEDICINE;
FOLLOW UP;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL SYMPTOM;
GYNECOLOGIC CANCER;
HUMAN;
INJECTION;
MEDICAL DECISION MAKING;
MENSTRUAL CYCLE;
MENSTRUAL IRREGULARITY;
NAUSEA;
ORAL CONTRACEPTION;
OVARY CYST;
PAPANICOLAOU TEST;
PARENT;
PATIENT CARE;
PATIENT COMPLIANCE;
PATIENT COUNSELING;
PATIENT EDUCATION;
PRACTICE GUIDELINE;
PREMENSTRUAL SYNDROME;
PRIORITY JOURNAL;
REVIEW;
RISK BENEFIT ANALYSIS;
SEXUAL BEHAVIOR;
TAMPON;
VOMITING;
|
EID: 0242268899
PISSN: 10833188
EISSN: None
Source Type: Journal
DOI: 10.1016/S1083-3188(03)00161-X Document Type: Article |
Times cited : (1)
|
References (0)
|